LOS ALTOS, Calif.--(BUSINESS WIRE)--May 18, 2005--The George Eliava Institute of Bacteriophage, Microbiology and Virology, Republic of Georgia, and Phage International Inc., Los Altos California, announced that they have signed an agreement whereby Eliava will become the supplier of bacteriophages for PII's new Phage Therapy Center in Tijuana Mexico. This is the first commercial use of phages in a medical clinic in the western world and marks a starting point in the promising collaboration between a scientific research center in the Republic of Georgia and a US owned Company. The Institute will test bacterial cultures from PTC patients for PIO-phage susceptibility, produce the appropriate phage and deliver it to PTC to eradicate the bacteria in suffering patients.
"We are delighted that through this cooperation with the Eliava Institute, Phage Therapy Center Mexico will now be able to provide better access to this medical technology," said Ronald Goossens, president PII. "We look forward to making bacteriophage treatments more broadly available in the future".
